| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |